News
To heighten its projects on the molecular and cellular virology of the Crimean-Congo hemorrhagic fever virus (CCHFV), HEAL, the Hepatotropic & Emerging Agents Laboratory is seeking to recruit: - A post-doctoral scientist in molecular virology - An Engineer in molecular and cellular biology
Interventions de chercheurs du CIRI autour de l'excellente exposition du musée des confluences "Epidémies, prendre soin du vivant"
François-Loïc Cosset and Solène Denolly. JBC, 2024. DOI: 10.1016/j.jbc.2024.107849
Fondation pour le Recherche Médicale
Embark with a scientist for a surprise and confidential mini-conference, in the form of a boat trip on the lake of the Parc de la Tête d'Or. Romain Barnault (HepVir team) will represent CIRI.
— Parc de la Tête d'OrCIRI members gathered for a party with outdoor games and a giant paella to share on Friday, June 14.
Last year more than 40 researchers gathered in Rome for the first HERVCOV project annual meeting. This year it's time to visit another of the project partners' cities and the 2nd Annual Meeting will be held in Zaragoza, headquarters of the Instituto Aragonés de Ciencias de la Salud (IACS) and IIS Aragón.
Every year, the Pint of Science festival brings together scientists and the curious for 3 evenings of popularizing science in bars. Here's a look back at CIRI doctoral students' participation in the 2024 edition!
In a new study published in the journal Autophagy, CIRI researchers have shown for the first time that, in patients with Crohn's disease, the expression of autophagic gene variants strongly affects autophagic dynamics, known as autophagic flux.
Teams from the Immunology Department of the Pitié-Salpêtrière AP-HP hospital, Inserm and Sorbonne University, coordinated by Prof. Guy Gorochov, have conducted a study on the ability of Covid-19 mRNA vaccines to induce a mucosal immune response. CIRI members took part in this study. The results were published in JAMA Network Open on April 23, 2024.
Members of the CIRI contributed to two books that were recently published. One is about the history of microbiology, and the other tackles research progress linked to the COVID-19 pandemic.
David Durantel (HepVir team and virology specialty coordinator) was elected President Elect of the ISAR (International Society for Antiviral Research), thus strenghtening the role of CIRI researchers in the international area of virology and antiviral research!
The RESPIVIR France - Canada International Research Laboratory was very well received at the 21st alternating meeting between the Quebec and French prime ministers, François Legault and Gabriel Attal, which took place in Quebec from April 10 to 12.
On Wednesday January 24, 2024, Université Claude Bernard Lyon 1 (UCBL), Hospices Civils de Lyon (HCL) (HCL), the French National Research Agency (ANR) and Sanofi officially launched the the VIRESP industrial chair, a research project focusing on the development of techniques and tools for analyzing the risk of infection and the morbidity rate of diseases in different populations, but also to determine the benefits of vaccination programs.
On March 19, the local finale of Ma Thèse en 180 secondes will take place, with the 12 finalists. Among them, two are doing their PhD at the CIRI: Xanthe Adams-Ward (LegioPath) et Iris Dadole (Persist).
— Grand Amphithéâtre de l'Université de Lyon - 90 rue Pasteur 69007 Lyon - et en direct sur YoutubeFebruary 29, 2024 is Rare Disease Day. This is an opportunity to thank the clinicians and researchers who are advancing research on this subject at CIRI, as well as our patients!
The ARC Foundation brings together 5 leading cancer researchers for a 45-minute program. It will give the floor to experienced researchers and young talents, all ready to take up, together, the challenges of curing more patients.
The VirPath team was awarded two times during the 2023 research and innovation awards ceremony of the Université Claude Bernard Lyon 1. We look back at these awards and on the research program of the International Associate Laboratory RESPIVIR France-Canada.
Meet with Cyrille Mathieu at the Yggdrasil festival, to learn all about viruses!
— Eurexpo LyonDuring the COVID-19 pandemic, multisystemic inflammatory syndrome affected 1,100 children. Since this first description in 2020, CIRI researchers, HCL clinicians and other international collaborators have discovered that this syndrome existed before COVID-19, and that other infectious agents could lead to this severe inflammatory syndrome in children. These findings are published in the New England Journal of Medicine.
Among the 11 laureates of the PEPR MIE 2023 call for projects (ANRS|Emerging Infectious Diseases), 6 projects involve CIRI teams. Their common aim is to better understand, prevent and control the emergence or re-emergence of infectious diseases.
The PHE3ID/CERP research team has been awarded with one of the first Projets d’Amorçage supported by SHAPE-Med@Lyon
On october 11, the Chaire industrielle REVIDA about respiratory infectious diseases, led by the researcher Sophie Trouillet-Assant (UCBL/HCL), was officially launched by the Université Claude Bernard Lyon 1, the Hospices Civils de Lyon, and bioMérieux, with the support of the Agence nationale de la recherche. It should enable the improvement of the capacity of health systems to face the emerging of new respiratory diseases.
On October 12, 2023, Sidaction donors visited the laboratory of the LP2L team (A. Cimarelli, L. Etienne). Here's a look back at this successful moment of sharing.
Le CIRI est représenté, ces mardi 23 et mercredi 24 mai 2023, au meeting du Réseau National des Hépatites virales qui se déroule à Paris.
New publication - VIV Team in Nature communication